SODIUM BICARBONATE
Injection, USP FOR THE CORRECTION OF METABOLIC ACIDOSIS AND OTHER CONDITIONS REQUIRING SYSTEMIC ALKALINIZATION Glass VialRx only
Approved
Approval ID
da484a2f-154f-48b4-8467-7a86729204c3
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Nov 14, 2023
Manufacturers
FDA
Henry Schein, Inc.
DUNS: 012430880
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
sodium bicarbonate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code0404-9951
Application NumberANDA202981
Product Classification
M
Marketing Category
C73584
G
Generic Name
sodium bicarbonate
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateNovember 14, 2023
FDA Product Classification
INGREDIENTS (2)
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM BICARBONATEActive
Quantity: 42 mg in 1 mL
Code: 8MDF5V39QO
Classification: ACTIB